Oisín Biotechnologies

Oisín Biotechnologies is a biotechnology company developing genetic medicines to treat age-related diseases. They utilize the Fusogenix Proteo-Lipid Vehicle (PLV) technology for targeted DNA delivery, focusing initially on therapies to eliminate unwanted fat cells and build muscle mass.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $15M

Date: 24-Jul-2024

Investors: AbbVie Ventures

Markets: Biotechnology, Genetic Medicine, Biopharma, Medical

HQ: Seattle, Washington, United States

Founded: 2014

Website: https://www.oisinbio.com

LinkedIn: https://www.linkedin.com/company/oisin-biotechnologies

Twitter: https://twitter.com/OisinBio

Instagram: